Streetbeat News

Stock Prices

CFLT

Confluent (NASDAQ:CFLT) has received diverse analyst ratings over the last three months, with 17 analysts offering evaluations ranging from bullish to bearish. The average 12-month price target for CFLT has been raised to $32.41, up 19.68% from the previous $27.08, indicating a positive outlook from analysts. Recent actions include upgrades and maintenance of buy and outperform ratings, with price targets adjusted accordingly. Despite this, Confluent's financial performance shows challenges in market capitalization, revenue growth, net margin, ROE, ROA, and debt management, suggesting potential hurdles ahead.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 12:00 pm

ADI

Analog Devices reported Q1 2024 adjusted EPS of $1.73, surpassing the $1.71 estimate, with sales of $2.51B also beating the $2.50B estimate. However, this represents a 22.68% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:00 pm

BLCO

Bausch & Lomb (BLCO) reported Q4 earnings of $0.24 per share, surpassing the $0.17 estimate, marking a 41.18% beat and a 4.35% increase from last year. Sales reached $1.17B, exceeding the $1.02B estimate by 15.34% and showing a 17.77% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 12:00 pm

NEO

NeoGenomics (NASDAQ:NEO) received mixed ratings from 4 analysts, with an average 12-month price target of $21.25, reflecting a 6.26% decline from the previous target. The company, specializing in cancer-focused genetic testing, shows a revenue growth of 17.99% but struggles with profitability, having a net margin of -12.19% and ROE of -1.95%. Despite these challenges, its debt-to-equity ratio of 0.64 indicates a sound financial structure.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 12:00 pm

CSGP

CoStar Group (NASDAQ:CSGP) received mixed analyst ratings over the last quarter, with a shift towards more bullish views in the last 30 days. The average 12-month price target for CSGP has risen to $93.4, up 8.19% from the previous $86.33. Analyst actions include adjustments to ratings and price targets by firms such as Needham, JMP Securities, Goldman Sachs, and BMO Capital. CoStar Group, a leader in commercial real estate data, has shown strong financial performance with significant revenue growth, high net margin, and excellent ROE and ROA, positioning it above industry averages.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 12:00 pm

GIL

Gildan Activewear projects its FY24 revenue growth to range from flat to a low-single digit increase. The company also forecasts its FY24 adjusted EPS to be between $2.92 and $3.07, compared to the $3 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:59 am

XPRO

Expro Gr Hldgs (NYSE:XPRO) reported Q4 adjusted EPS of $0.06, missing the $0.10 estimate, a 72.73% decrease from last year. Sales were $406.75M, beating the $382.91M estimate, up 15.89% from last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:59 am

GIL

Gildan Activewear (NYSE:GIL) reported Q4 adjusted EPS of $0.75, surpassing the $0.73 estimate, and sales of $783M, exceeding the $764.48M estimate. This represents a 15.38% increase in earnings and an 8.75% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:55 am

PLL

Piedmont Lithium (NASDAQ:PLL) announced the sale of its entire stake in Sayona Mining (ASX: SYA), totaling 1,152.2 million shares at A$0.052/share, through Canaccord Genuity. The sale, generating approximately A$59.9 million (US$39.4 million), concludes Piedmont's shareholding in Sayona, without affecting its joint venture or offtake position with Sayona Quebec.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:53 am

EXC

Exelon (NASDAQ:EXC) reported Q4 adjusted earnings of $0.60 per share, surpassing the $0.58 estimate, marking a 39.53% increase from last year. Sales reached $5.37B, beating the $4.17B estimate, a 15.02% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:53 am